Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients
Clinical trial NCT06199037 · TERMINATED
Trial details
- NCT number
- NCT06199037
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-05
- Primary completion
- 2026-01-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.